Viehbacher Discusses Sanofi-Genzyme on Jan. 26

Jan. 26 (Bloomberg) -- Chris Viehbacher, chief executive officer of Sanofi-Aventis SA, discusses his company's takeover talks with Genzyme Corp. Sanofi, based in Paris, two days ago extended its takeover offer for Genzyme a second time, giving France's biggest drugmaker more time to reach an agreement with the U.S. biotechnology company. The $18.5 billion offer is now set to expire on Feb. 15. Viehbacher speaks in Davos, Switzerland. (Source: Bloomberg)